{"url":"https://lda.senate.gov/api/v1/filings/a26bb64f-17b3-4c7b-bf64-963da08cf475/","filing_uuid":"a26bb64f-17b3-4c7b-bf64-963da08cf475","filing_type":"2T","filing_type_display":"2nd Quarter - Termination","filing_year":2011,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/a26bb64f-17b3-4c7b-bf64-963da08cf475/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Donna F. Mullins, Managing Partner","dt_posted":"2011-07-20T09:09:46.460000-04:00","termination_date":"2011-04-30","registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"819 7TH STREET, NW","registrant_address_2":"SUITE 501","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":50796,"url":"https://lda.senate.gov/api/v1/registrants/50796/","house_registrant_id":34724,"name":"WINNING STRATEGIES WASHINGTON","description":"Government relations firm","address_1":"409 7TH STREET, NW","address_2":"SUITE 450","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CARL CHIDLOW","contact_telephone":"+1 202-589-0800","dt_updated":"2026-01-28T09:17:29.205119-05:00"},"client":{"id":157049,"url":"https://lda.senate.gov/api/v1/clients/157049/","client_id":1005305,"name":"MEDA PHARMACEUTICALS","general_description":"Pharmaceutical company specializing in respiratory and allergy products","client_government_entity":false,"client_self_select":false,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2011-02-02"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"FDA Risk Evaluation and Mitigation Strategies","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":43397,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"A","last_name":"MEROLA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":35503,"prefix":null,"prefix_display":null,"first_name":"ALEX","nickname":null,"middle_name":null,"last_name":"DELPIZZO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"FDA Risk Evaluation and Mitigation Strategies","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":43397,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"A","last_name":"MEROLA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":35503,"prefix":null,"prefix_display":null,"first_name":"ALEX","nickname":null,"middle_name":null,"last_name":"DELPIZZO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}